Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Trump claims ACA is dead—but IRS still plans to enforce employer mandate

At last week’s campaign-style rally in Michigan, President Donald Trump claimed he’d done away with the Affordable Care Act (ACA) when the 2017 tax bill repealed the individual mandate. But folks at the Internal Revenue Service (IRS), though, would disagree. A recent report from the New York Times examines IRS's plan to send out penalty notices to more than 30,000 businesses in the U.S.

Elliott makes $7B all-cash bid for Athenahealth

According to CNBC, Elliott Management made an all-cash deal for Athenahealth on Monday morning. Elliott’s bid is for $160 a share—a 27 percent premium to the Massachusetts-based healthcare technology company’s Friday afternoon price.

Lower health literacy results in poorer surgical recovery outcomes

For outpatient surgery, those with lower health literacy experienced poorer recovery and decreased quality of life, according to an April 25 study published in JAMA Surgery.

36% of readmissions at 7 days could be prevented

More than one-third of readmissions within seven days of discharge—36 percent—are preventable, according to research published May 1 in the Annals of Internal Medicine.

Thumbnail

Partners HealthCare talking merger with insurer Harvard Pilgrim

One of Massachusetts’ largest health insurers, Harvard Pilgrim, has been discussing a merger with the state’s dominant healthcare provider, Partners HealthCare, in a move that could dramatically alter the increasingly consolidated market in and around Boston.

Thumbnail

CMS’s Verma: Recent rules ‘only the beginning’ of pushing consumerism

In an article for RealClearHealth, CMS Administrator Seema Verma, MPH, said the industry can expect more proposals meant to push consumerism in healthcare along the lines of recent policies on price transparency and easier data sharing.

Thumbnail

HHS sued over failing to release communications on family planning grants, religious freedom

HHS is the target of new lawsuits by a watchdog group for failing to respond to requests to release emails and online messages—one regarding Office of Civil Rights (OCR) officials and launching of its “Conscience and Religious Freedom Division,” the other over HHS communications with outside groups on changes to a federal grant program that provides birth control and other reproductive health services to low-income Americans.

Thumbnail

5 things to know about state health system performance rankings

The Commonwealth Fund’s 2018 scorecard on state health system performance saw the five highest-ranked states maintain their exact rankings from the last report, with Hawaii again claiming the No. 1 spot. The most striking finding was the surge in deaths from suicide, alcohol and overdoses from opioids and other drugs since 2005.

Displaying 3569 - 3576 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup